GlassScriptPhysician profile
Gordon W Theisz
NPI 1437101508
$2,998.92
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $752 · 2021: $745 · 2022: $559 · 2023: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $582.49 | 2019-2022 | |
| Novo Nordisk INC | $437.30 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $320.58 | 2019-2022 | |
| Lilly USA, LLC | $180.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $176.54 | 2019-2021 | |
| Gilead Sciences, INC. | $146.33 | 2019-2020 | |
| Glaxosmithkline, LLC. | $145.99 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.50 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.79 | 2019-2022 | |
| Abbvie INC. | $101.20 | 2021-2022 | |
| Amarin Pharma, INC. | $81.83 | 2019-2021 | |
| Genentech USA, INC. | $65.63 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $51.92 | 2022 | |
| Allergan, INC. | $51.84 | 2020 | |
| Viiv Healthcare Company | $50.08 | 2022-2023 | Apretude |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $40.07 | 2021 | |
| Idorsia Pharmaceuticals US INC | $39.95 | 2023 | Quviviq |
| Exact Sciences Corporation | $36.39 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $32.13 | 2019 | |
| Sanofi Pasteur INC. | $27.05 | 2020-2023 | |
| Vanda Pharmaceuticals INC. | $23.28 | 2022 | |
| Abbott Laboratories | $21.95 | 2022 | |
| Hologic Sales and Service, LLC | $20.14 | 2022 | |
| Astellas Pharma US INC | $18.08 | 2023 | Veozah |
| Jazz Pharmaceuticals INC. | $17.49 | 2020 | |
| Endo Pharmaceuticals INC. | $14.14 | 2019 | |
| Esperion Therapeutics, INC. | $13.13 | 2021 | |
| Mayne Pharma Commercial LLC | $12.21 | 2022 | |
| Medtronic, INC. | $12.00 | 2022 | |
| Hikma Pharmaceuticals USA | $11.28 | 2020 | |
| Vbi Vaccine (Delaware) INC. | $11.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Theisz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.